Incidence of oculogyri ccrisis and long-term out comes with second-generation antipsychotics in a first-episode psychosis program

Journal of Clinical Psychopharmacology

Volumn 35, Issue 6, 2015, Pages 715-718

  Gardner, David M ^a,b   Abidi, Sabina ^a,b   Ursuliak, Zenovia ^a,b   Morrison, Jason ^a,b   Teehan, Michael D ^a,b   Tibbo, Philip G ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Nova Scotia Health Authority (NSHA)   (Canada)

Author keywords

first episode psychosis; incidence; oculogyric crisis; second generation antipsychotics; tardive dystonia

Indexed keywords

ALPHA TOCOPHEROL; ARIPIPRAZOLE; BENZATROPINE; CLOZAPINE; DIPHENHYDRAMINE; LORAZEPAM; LOXAPINE; LURASIDONE; NEUROLEPTIC AGENT; NICOTINIC ACID; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY INTERVENTION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MALE; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; OCULOGYRIC CRISIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RECURRENT DISEASE; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; CHEMICALLY INDUCED; DYSTONIA; INCIDENCE; NOVA SCOTIA; OCULAR MOTILITY DISORDERS; OUTCOME ASSESSMENT; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; DYSTONIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NOVA SCOTIA; OCULAR MOTILITY DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTIC DISORDERS; RECURRENCE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84947042558     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000411     Document Type: Article

References (33)

1. BhattM, Sethi KD, Bhatia K. Acute and tardive dystonia. In: Sethi KD, ed. Drug-Induced Movement Disorders. New York: Marcel Dekker; 2004: 111-128.
2. FitzGerald PM, Jankovic J. Tardive oculogyric crises. Neurology. 1989;39: 1434-1437.
3. Sachdev P. Tardive and chronically recurrent oculogyric crises. Mov Disord. 1993;8:93-97.
4. Gardner DM, Teehan MD. Antipsychotics and Their Side Effects. Cambridge, UK: Cambridge University Press; 2011.
5. Schneider SA, Udani V, Sankhla CS, et al. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs. Mov Disord. 2009;24:1226-1229.
6. Abe K. Psychiatric symptoms associated with oculogyric crisis: a review of literature for the characterization of antipsychotic-induced episodes. World J Biol Psychiatry. 2006;7:70-74.
7. Praharaj SK, Sarkhel S, Akhtar S. Stereotyped paroxysmal psychiatric symptoms during oculogyric crisis or 'cognitive dystonia': a case report. Curr Drug Saf. 2011;6:49-50.
8. Rosenhagen MC, Schmidt U, Winkelmann J, et al. Olanzapine-induced oculogyric crisis. J Clin Psychopharmacol. 2006;26:431.
9. Desarkar P, Das A, Sinha VK. Olanzapine-induced oculogyric crisis. Aust N Z J Psychiatry. 2006;40:374.
10. Vahia VN, Naik PM, Deotale P. Unusual case reports: tardive oculogyric crisis (tardive syndromes). Indian J Psychiatry. 2007;49:219-220.
11. Chakraborty R, Chatterjee A, Chaudhury S. Olanzapine-induced oculogyric crisis in a patient with schizophrenia. Indian J Med Sci. 2008; 62:238-239.
12. Praharaj SK, Jana AK, Sarkar S, et al. Olanzapine-induced tardive oculogyric crisis. J Clin Psychopharmacol. 2009;29:604-606.
13. Ghosh S, Dhrubajyoti B, Bhattacharya A, et al. Tardive oculogyric crisis associated with quetiapine use. J Clin Psychopharmacol. 2013;33:266.
14. DaveM. Tardive oculogyric crises with clozapine. J Clin Psychiatry. 1994; 55:264-265.
15. Mendhekar DN, Duggal HS. Isolated oculogyric crisis on clozapine discontinuation. J Neuropsychiatry Clin Neurosci. 2006;18:424-425.
16. Uzun O, Doruk A. Tardive oculogyric crisis during treatment with clozapine: report of three cases. Clin Drug Investig. 2007;27:861-864.
17. Chakraborty R, Chatterjee A. Clozapine-induced oculogyric crises. Ann Pharmacother. 2007;41:1916.
18. Khalid A, Nepal MK. Risperidone-induced oculogyric crisis. Indian J Psychiatry. 2000;42:449-450.
19. Mazurek MF, Rosebush PI. Acute drug-induced dystonia. In: Factor SA, Lang AE, Weiner WJ, eds. Drug induced movement disorders. 2nd eds. Blackwell Futura: Malden, MA; 2005:72-102.
20. Masliyah T, Ad-Dab'bagh Y. Low-dose risperidone-induced oculogyric crises in an adolescent male with autism, tourette's and developmental delay. J Can Acad Child Adolesc Psychiatry. 2011;20:214-216.
21. Fountoulakis KN, Siamouli M, Kantartzis S, et al. Acute dystonia with low-dosage aripiprazole in tourette's disorder. Ann Pharmacother. 2006;40:775-777.
22. Lim HK, Pae CU, Lee C, et al. Tardive dystonic symptoms associated with aripiprazole treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:589-590.
23. Bhachech JT. Aripiprazole-induced oculogyric crisis (acute dystonia). J Pharmacol Pharmacother. 2012;3:279-281.
24. Ramos AE, Shytle RD, Silver AA, et al. Ziprasidone-induced oculogyric crisis. J Am Acad Child Adolesc Psychiatry. 2003;42: 1013-1014.
25. Gupta S, Nolan TN, Frank BL. Case report of oculogyric crisis with ziprasidone in a minor. Prim Care Companion J Clin Psychiatry. 2008; 10:254-255.
26. Viana Bde M, Prais HA, Camargos ST, et al. Ziprasidone-related oculogyric crisis in an adult. Clin Neurol Neurosurg. 2009;111:883-885.
27. Canadian Pharmacists Association. Risperdal tablets/Risperdal oral Solution/Risperdal M-tab. e-compendium of pharmaceuticals and specialties. Available at: https://www. e-therapeutics. ca/. Accessed April 9, 2015.
28. Canadian Pharmacists Association. Zeldox. e-compendium of pharmaceuticals and specialties. Available at: https://www. e-therapeutics. ca/. Accessed April 9, 2015.
29. Yassa R, Nair V, Iskandar H. A comparison of severe tardive dystonia and severe tardive dyskinesia. Acta Psychiatr Scand. 1989;80:155-159.
30. Yassa R, Nair V, Dimitry R. Prevalence of tardive dystonia. Acta Psychiatr Scand. 1986;73:629-633.
31. Swett C Jr. Drug-induced dystonia. Am J Psychiatry. 1975;132:532-534.
32. Kiriakakis V, Bhatia KP, Quinn NP, et al. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain. 1998;121 (Pt 11):2053-2066.
33. Skidmore F, Weiner WJ, Burke R. Neuroleptic-induced tardive dyskinesia variants. In: Factor SA, Lang AE, Weiner WJ, eds. Drug Induced Movement Disorders. 2nd eds. Blackwell Futura: Malden, MA; 2005: 257-284.